INTRODUCTION Despite major advances in rheumatoid arthritis (RA) treatment and the improved outcomes that have been associated with the expanding number of disease-modifying antirheumatic drugs (DMARDs) available, a substantial number of patients are refractory to multiple biologics, highlighting a persistent unmet need in patients with RA.1-4 The term “refractory RA” (reRA) characterizes a state of persistent inflammation, symptoms, or disease activity despite exposure to multiple advanced...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Sofia Pedro
Associations Between Smartphone‐Derived Behavioral Data and Rheumatoid Arthritis Flares
INTRODUCTION Rheumatoid arthritis (RA) is characterized by sporadic and debilitating symptoms like increased pain, inflammation, and decreased mobility which intensify during a “flare.”1-3 A flare is a transient episode of increased disease activity or symptom exacerbation, during which conventional treatments may have reduced efficacy.4 Recurring flares disrupt an individual's daily routine and affect their ability to work, pose a significant risk to their overall quality of life, and...
Opioid Use and Healthcare Utilization in Adults With Psoriatic Arthritis and Ankylosing Spondylitis
Opioid Use and Healthcare Utilization in Adults With Psoriatic Arthritis and Ankylosing Spondylitis Jean W. Liew, Sofia Pedro, Kaleb Michaud, Alexis Ogdie The Journal of Rheumatology Oct 2024, 51 (10) 1009-1014; DOI: 10.3899/jrheum.2024-0127
Treatment Adherence and Adherence Patterns of Tofacitinib and Self‐Injectable TNFi Use in People with Rheumatoid Arthritis
INTRODUCTION Rheumatoid arthritis (RA) is a chronic autoimmune disease associated with reduced physical function and increased pain, morbidity, and mortality that affects around 0.7% of the US population. Treatment with disease-modifying antirheumatic drugs (DMARDs) is required for control of RA activity. Methotrexate (MTX), a conventional synthetic DMARD, has long been the gold standard and initial choice of treatment for RA.
Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis
Handling editor Josef S Smolen Twitter @Dr_K Contributors All authors met the authorship criteria, they had a substantial contribution to the conception or design of the work (GO, SP, KM) or the acquisition (GO, SP, KM), analysis (GO, SP, KM) or interpretation of data for the work (all authors) and were involved in revising a draft of this work, gave final approval of this version and are accountable for all aspects of the work in ensuring accuracy and integrity.
Urban/rural Patterns of Healthcare Utilization among People with Rheumatoid Arthritis and Osteoarthritis in a large U.S. patient registry
Supporting Information Filename Description acr25192-sup-0001-Disclosureform.pdfapplication/docx, 307.3 KB Disclosure Form acr25192-sup-0001-Supinfo.docxWord 2007 document , 34.4 KB Supporting Information
Reply
Corresponding Author Patricia Katz PhD University of California San Francisco, San Francisco, CA Correspondence: Patricia Katz, PhD, University of California San Francisco, Zuckerberg San Francisco General Hospital, 1001 Potrero Ave. Building 30, 3rd Floor, Room 3301, San Francisco, CA 94110, Phone: 415-476-5971, Fax: 415-476-9030, Email: patti.katz@ucsf.edu Search for more papers by this author
Reply
Reply This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/acr.25208.
Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis
http://orcid.org/0000-0002-5423-393XGulsen Ozen1, Sofia Pedro2, http://orcid.org/0000-0002-5350-3934Kaleb Michaud1,2 1Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA 2FORWARD, The National Databank for Rheumatic Diseases, Wichita, Kansas, USA Correspondence to Dr Gulsen Ozen, Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA; ozengs{at}yahoo.com Abstract Objective Assess major adverse cardiovascular event (MACE) risk with opioids compared with...
Urban/rural Patterns of Healthcare Utilization among People with Rheumatoid Arthritis and Osteoarthritis in a large U.S. patient registry
Abstract Objective Rural residence has been associated with health disparities in rheumatic diseases and other chronic conditions in the United States. This study aimed to determine if a relationship exists between geographic residence and healthcare utilization outcomes for people with rheumatoid arthritis (RA) and osteoarthritis (OA) in a U.S.-wide rheumatic disease registry.
Physical Activity Habits Among Older Adults Living With Rheumatic Disease
METHODS Study sample. A cross-sectional study was performed within the FORWARD database/The National Databank (NDB) for Rheumatic Diseases (now called the Forward Databank), the largest patient-reported databank in the US. The FORWARD database/NDB is a patient-based multidisease registry, though the largest cohorts are patients with RA, SLE, fibromyalgia syndrome (FMS), SpA, and OA. All are patient-reported diagnoses, though most were also confirmed through a questionnaire to the provider.
Obesity, adipokines, and chronic and persistent pain in rheumatoid arthritis.
We aimed to determine whether adipokines are associated with pain and polysymptomatic distress in patients with rheumatoid arthritis (RA) over time in a large patient registry.
Physical Activity Habits Among Older Adults Living With Rheumatic Disease
Thank you for your interest in spreading the word about The Journal of Rheumatology. NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas.
Reduction of Cardiovascular Disease and Mortality Versus Risk of New‐Onset Diabetes Mellitus With Statin Use in Patients With Rheumatoid Arthritis
Data source and study population We conducted a prevalent new-user cohort study within the UK Clinical Practice Research Datalink (CPRD) and linked events data of the Hospital Episode Statistics (HES) and Office of National Statistics (ONS) databases. The CPRD is a UK government, nonprofit research service including anonymized general practitioner (GP) electronic health records on >11 million patients since 1987 (24).
Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis
Abstract Objective The present study was undertaken to evaluate whether the rate of incident chronic opioid use is higher in obese patients with rheumatoid arthritis (RA). Methods Participants with RA in the FORWARD databank were asked about their use of weak and strong opioid medications on semiannual surveys. Incident chronic opioid use was defined as new reported use extending over 2 contiguous surveys (~7–12 months).
Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?
Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?
DMARD Changes for Patients with Rheumatoid Arthritis in the US During the COVID‐19 Pandemic: A 3‐Month Observational Study
ORIGINAL ARTICLE Kaleb Michaud, Corresponding Author kmichaud@unmc.edu orcid.org/0000-0002-5350-3934 FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS, USA University of Nebraska Medical Center, Department of Internal Medicine, Division of Rheumatology and Immunology, Omaha, NE, USA Corresponding author: Kaleb Michaud, University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198 kmichaud@unmc.edu Search for more papers by this author Sofia Pedro,...
The Risk of Cardiovascular Events Associated With Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis
Abstract Objective To examine the comparative effects of biologic disease-modifying antirheumatic drugs (bDMARD) and tofacitinib against conventional synthetic DMARD (csDMARD) on incident cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA).
The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis
Research ArticleAccepted Article Gulsen Ozen, Sofia Pedro and Kaleb Michaud The Journal of Rheumatology August 2020, jrheum.200265; DOI: https://doi.org/10.3899/jrheum.200265 Abstract Objective To examine the comparative effects of biologic disease-modifying antirheumatic drugs (bDMARDs) and tofacitinib against conventional synthetic (cs) DMARDs on incident cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA).
Safety of Abatacept Compared With Other DMARDs in RA
close Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
Medications associated with fracture risk in patients with rheumatoid arthritis
Medications associated with fracture risk in patients with rheumatoid arthritis Gulsen Ozen1, Sofia Pedro2, Frederick Wolfe2, Kaleb Michaud1,2 1 University of Nebraska Medical Center, Omaha, Nebraska, USA 2 Forward, The National Databank for Rheumatic Diseases, Wichita, Kansas, USA Correspondence to Dr Kaleb Michaud, National Data Bank for Rheumatic Diseases, Wichita, KS 67214, USA; kmichaud{at}unmc.edu Abstract Objective To examine the fracture risk with use of disease-modifying...
Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study
Arthritis Research & Therapy201921:141 https://doi.org/10.1186/s13075-019-1921-z © The Author(s).
Medications associated with fracture risk in patients with rheumatoid arthritis
Medications associated with fracture risk in patients with rheumatoid arthritis Gulsen Ozen1, Sofia Pedro2, Frederick Wolfe2, Kaleb Michaud1,2 1University of Nebraska Medical Center, Omaha, Nebraska, USA 2Forward, The National Databank for Rheumatic Diseases, Wichita, Kansas, USA Correspondence to Dr Kaleb Michaud, National Data Bank for Rheumatic Diseases, Wichita, KS 67214, USA; kmichaud{at}unmc.edu Abstract Objective To examine the fracture risk with use of disease-modifying antirheumatic...
Response to: ‘Statin therapy now more common than steroids in clinical practice’ by Pareek and Chankurdar
We appreciate the interest shown by Pareek and Chankurdar1 concerning our recent study on diabetes mellitus (DM) risk associated with disease-modifying antirheumatic drugs and statins in patients with rheumatoid arthritis (RA).2 They pointed out that statin-associated DM risk in patients with RA might be a more important concern than the risk attributed to glucocorticoids (GCs) due to longer treatment durations.1 We agree that statin treatment is potentially continued for a longer duration...
Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis
Objective To investigate the rate of incident diabetes mellitus (DM) in patients with rheumatoid arthritis (RA) and the impact of disease-modifying antirheumatic drug (DMARD) and statin treatments. Methods We studied patients with RA and ?1?year participation in the National Data Bank for Rheumatic Diseases without baseline DM from 2000 through 2014. DM was determined by self-report or initiating DM medication.
Response to: ‘Statin therapy now more common than steroids in clinical practice’ by Pareek and Chandurkar
We appreciate the interest shown by Pareek and Chandurkar1 concerning our recent study on diabetes mellitus (DM) risk associated with disease-modifying antirheumatic drugs and statins in patients with rheumatoid arthritis (RA).2 They pointed out that statin-associated DM risk in patients with RA might be a more important concern than the risk attributed to glucocorticoids (GCs) due to longer treatment durations.1 We agree that statin treatment is potentially continued for a longer duration...
Response to: ‘Statin therapy now more common than steroids in clinical practice’ by Pareek and Chankurdar
We appreciate the interest shown by Pareek and Chankurdar1 concerning our recent study on diabetes mellitus (DM) risk associated with disease-modifying antirheumatic drugs and statins in patients with rheumatoid arthritis (RA).2 They pointed out that statin-associated DM risk in patients with RA might be a more important concern than the risk attributed to glucocorticoids (GCs) due to longer treatment durations.1 We agree that statin treatment is potentially continued for a longer duration...
Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis
Objective To investigate the rate of incident diabetes mellitus (DM) in patients with rheumatoid arthritis (RA) and the impact of disease-modifying antirheumatic drug (DMARD) and statin treatments. Methods We studied patients with RA and ?1?year participation in the National Data Bank for Rheumatic Diseases without baseline DM from 2000 through 2014. DM was determined by self-report or initiating DM medication.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Sofia
Contact Sofia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack